Scott Martin
Physician Assistant · Watkinsville, GANPI 1639154040
Payments from drug & device makers
Across 155 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$573
- Boehringer Ingelheim$340
- AbbVie$328
- Amgen$143
- Astellas Pharma US Inc$139
- AstraZeneca$137
- plus $937 from 16 others
What the payments were for
- Food & beverage$2,596100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $573 |
| Boehringer Ingelheim | 19 | $340 |
| AbbVie | 20 | $328 |
| Amgen | 10 | $143 |
| Astellas Pharma US Inc | 8 | $139 |
| AstraZeneca | 9 | $137 |
| Sanofi-aventis U.S. LLC | 7 | $122 |
| GSK | 6 | $121 |
| Bayer | 5 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $94 |
| Exact Sciences | 4 | $90 |
| Lilly USA, LLC | 5 | $70 |
| Pfizer | 3 | $61 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Johnson & Johnson | 3 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$2,596 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $20,728 |
| JardianceEmpagliflozin | 14 | $15,979 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,588 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $767 |
| Atorvastatin Calcium | 55 | $588 |
| Lisinopril | 32 | $294 |
| Simvastatin | 17 | $289 |
| Omeprazole | 25 | $268 |
| Fluticasone Propionate | 38 | $265 |
| Levothyroxine Sodium | 24 | $245 |
| Glipizide ErGlipizide | 11 | $212 |
| Doxycycline Hyclate | 20 | $209 |
| Gabapentin | 16 | $185 |
| Trazodone Hcl | 23 | $175 |
| Tamsulosin Hcl | 18 | $174 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $573 | $20,72820 claims |
| Boehringer IngelheimJardiance | $340 | $15,97914 claims |
| AstraZenecaSymbicort | $137 | $2,58811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Watkinsville
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$887K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.